entertainment -WSS

entertainment

author：fashion 2025-10-02 04:55:33 - browse：4926

Senate Health, Education, Labor, and Pensions Committee Chairman Bernie Sanders looks at Moderna CEO Stephane Bancel as he testifies. Sitting next to Sanders, ranking member Sen. Bill Cassidy looks down – policy coverage from STAT — Committee Ranking Republican Bill Cassidy (La.) and Chairman Bernie Sanders (I-Vt.) Chip Somodevilla/Getty Images

WASHINGTON – The Senate health committee on Thursday passed a package of bills aimed at speeding generic drug competition and reining in drug middlemen business practices. But they failed to pass an ambitious reform to the pharmacy benefit manager sector, despite strong bipartisan support for it.

Chairman Bernie Sanders (I-Vt.) is pursuing the drug pricing reforms at the behest of Senate Majority Leader Chuck Schumer (D-N.Y.), who wants to hold a floor vote on an even bigger package of health bills later this year. The markup came just a day after the same panel held a major hearing on PBM and drugmakers’ role in high insulin prices.

It’s not clear when the Senate would take up that package, and while the package is bipartisan, it’s not clear whether it has enough support among House Republicans to pass in that chamber. There are a few, tamer PBM bills that the House Energy and Commerce Committee is expected to mark up May 17, but there is no indication that Senate and House lawmakers are coordinating on PBM legislation.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Criminal prosecution for violating HIPAA: an emerging threat

entertainment

WSS

Indian pharmaceutical industry in denial over drug

Jury awards Florida girl burned by McDonald's Chicken McNugget $800,000 in damages

Wife of Gilgo Beach murder suspect files for divorce, court filing shows

Readers respond to H5N1 and livestock movements, and more

It's time to retire 'poor historian' from clinicians' vocabularies

Tocagen's brain cancer gene therapy trial continues. Investors worry

hotspot

entertainment

hotspot

United colonoscopy coverage change 'may cost lives,' doctors say

Wife of Gilgo Beach murder suspect files for divorce, court filing shows

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Indian pharmaceutical industry in denial over drug

FDA approval of Sarepta Duchenne genetic therapy gives me hope

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

Jerome Adams on the need for new antivirals for Covid

Texas Department of Public Safety speaks out on migrant abuse allegations

In age of alternative facts, a scholarly course on calling out crap

Venture capitalist Bob Kocher on the state of digital health

focus

Driven by the pandemic, applicants flood public health schools

Tocagen's brain cancer gene therapy trial continues. Investors worry

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

Readers respond to H5N1 and livestock movements, and more

EF3 tornado rips through North Carolina amid extreme weather nationwide

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

hotspot

focus

entertainment

hotspot